JP2004533206A5 - - Google Patents

Download PDF

Info

Publication number: JP2004533206A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2002534562A

Other languages

Other versions

Filing date

2001-10-11

Publication date

2005-12-22

2001-10-11 Application filed filed Critical

2001-10-11 Priority claimed from PCT/US2001/031607 external-priority patent/WO2002031198A2/en

2004-11-04 Publication of JP2004533206A publication Critical patent/JP2004533206A/en

2005-12-22 Publication of JP2004533206A5 publication Critical patent/JP2004533206A5/ja

Status Pending legal-status Critical Current

JP2002534562A 2000-10-11 2001-10-11 Cancer-related genes as targets for chemotherapy Pending JP2004533206A (en)

Application Number	Priority Date	Filing Date	Title
US23929700P	2000-10-11	2000-10-11
US23929400P	2000-10-11	2000-10-11
US23960500P	2000-10-11	2000-10-11
US23980500P	2000-10-12	2000-10-12
US23980600P	2000-10-12	2000-10-12
US23980200P	2000-10-12	2000-10-12
US24062200P	2000-10-16	2000-10-16
US24172300P	2000-10-19	2000-10-19
US24168200P	2000-10-19	2000-10-19
US24493200P	2000-10-31	2000-10-31
PCT/US2001/031607 WO2002031198A2 (en)	2000-10-11	2001-10-11	Cancer-linked genes as targets for chemotherapy

Publication Number	Publication Date
JP2004533206A JP2004533206A (en)	2004-11-04
JP2004533206A5 true JP2004533206A5 (en)	2005-12-22

Application Number	Title	Priority Date	Filing Date
JP2002534562A Pending JP2004533206A (en)	2000-10-11	2001-10-11	Cancer-related genes as targets for chemotherapy

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030215445A1 (en)	1997-05-23	2003-11-20	Ginette Serrero	Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US7411045B2 (en)	2002-11-19	2008-08-12	A&G Pharmaceutical, Inc.	Autocrine growth factor receptor antibodies and methods
ES2369695T3 (en)	2003-02-26	2011-12-05	A & G PHARMACEUTICAL, INC.	METHODS TO INCREASE THE PROLIFERATION OF CELLS B.
WO2005011590A2 (en)	2003-08-01	2005-02-10	A & G Pharmaceutical, Inc.	Compositions and methods for restoring sensitivity to treatment with her2 antagonists
GB0328928D0 (en) *	2003-12-12	2004-01-14	Cancer Rec Tech Ltd	Materials and methods relating to cell cycle control
US20050186577A1 (en)	2004-02-20	2005-08-25	Yixin Wang	Breast cancer prognostics
US8673268B2 (en)	2004-10-15	2014-03-18	Galapagos N.V.	Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
US7485468B2 (en)	2004-10-15	2009-02-03	Galapagos Bv	Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
WO2008066498A1 (en) *	2006-12-01	2008-06-05	Agency For Science, Technology And Research	Cancer-related protein kinases

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5668267A (en) *	1995-05-31	1997-09-16	Washington University	Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
AU2115197A (en) *	1996-01-30	1997-08-22	Melcorp Diagnostics, Inc.	Compositions and methods useful in the detection and/or treatment of cancerous conditions
US6007991A (en) *	1997-03-28	1999-12-28	The Research Foundation Of Suny	Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
EP1053319A2 (en) *	1998-01-28	2000-11-22	Chiron Corporation	Human genes and gene expression products ii
WO2001042467A2 (en) *	1999-12-08	2001-06-14	Millennium Pharmaceuticals, Inc.	Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2001060860A2 (en) *	2000-02-17	2001-08-23	Millennium Predictive Medicine, Inc.	Genes differentially expressed in human prostate cancer and their use